Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000094 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 18, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
30,726
Total Value
$452,033.46
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 3,542 | $10.20 | $36,128.40 | 66,985 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 15, 2026 | Sale | 9,890 | $23.81 | $235,486.83 | 57,095 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 4,167 | $14.25 | $59,379.75 | 61,262 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 417 | $15.44 | $6,438.48 | 61,679 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 17, 2026 | Sale | 4,584 | $25.00 | $114,600.00 | 57,095 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jun 15, 2026 | Exercise/Conversion | 3,542 | $0.00 | $0.00 | 113,334 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jun 17, 2026 | Exercise/Conversion | 4,167 | $0.00 | $0.00 | 83,334 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jun 17, 2026 | Exercise/Conversion | 417 | $0.00 | $0.00 | 3,750 | Direct | โ | View Details |